Moreover, we recently revealed that brexpiprazole exhibits anticancer activity against several types of cancer, including glioblastoma, and chemosensitizes CSCs of pancreatic cancer and NSCLC to gemcitabine and 5-fluorouracil by downregulating survivin, an antiapoptotic protein [31]. This evidence concerns the gene BIRC5 and cancer.